CSTONE PHARMA-B (02616) Grants 15.7155 Million Share Options and 8.055 Million Restricted Share Units

Stock News
Jan 23

On January 23, 2026, the Board of Directors resolved to grant a total of 15.7155 million share options to 96 grantees under the Post-IPO Employee Share Option Scheme. Among the total of 15.7155 million share options granted, 7 million were awarded to one director, with the remaining 8.7155 million granted to the company's employees, including senior management members. On the same date, the Board also resolved to grant a total of 8.055 million Restricted Share Units (RSUs) to 88 RSU recipients under the Post-IPO Restricted Share Award Scheme. Of the total 8.055 million RSUs granted, 4.27 million were allocated to one director, while 3.785 million were awarded to the company's employees, including members of the senior management team.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10